Figure 4
From: Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
The expressions of CB1 and CB2 in HepG2 liver cells. A. The mRNA expression of CB1 and CB2 in HepG2 liver cells. B. The protein expression of CB1 and CB2 in HepG2 liver cells. C. The CB1 protein expression fold change in HepG2 cell, HepG2 fatty cell and rimonabant/HepG2-fatty cell was 0.28 ± 0.02,0.95 ± 0.04,0.12 ± 0.01 compare to B-actin as control, respectively (p < 0.05). HepG2; HepG2-fatty; Rimonabant/ HepG2-fatty. HepG2; HepG2-fatty. HepG2; HepG2-fatty; Rimonabant/HepG2-fatty.